
Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, …

Researchers at the Medical School at Harvard and MedUni Vienna’s Department of Ear, Nose and Throat Diseases have managed to …

GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …

Sanofi has signed a research pact with Audion Therapeutics to develop regenerative medicines for hearing loss. The company’s two-year deal …
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation

